CD34 and cancer: In this primary model, CD3+ cells within samples stimulated with J014-IgG4-Pro increased their interactions to CD34+ AML cancer cells (Figure 8A), and simultaneously an increase of surface CD107a expression was observed suggesting T cell activity (Figure 8B).